source
- Sarepta's Elevidys shows durable benefit in ambulatory Duchenne patients, analysts see turnaround potentialJefferies analysts said Sarepta Therapeutics could become a turnaround story after the company presented new data on its Duchenne muscular dystrophy gene therapy Elevidys. The late-breaking poster…
- Varda Space Industries secures $251 million to produce drugs in microgravityVarda Space Industries, a startup partnered with United Therapeutics, announced a $251 million Series D financing round. The funding, led by Lux Capital and Natural Capital, brings total capital r…